NDT Pharmaceuticals Inc. (NDTP)
OTCMKTS · Delayed Price · Currency is USD
0.6170
+0.030144 (5.14%)
At close: Jun 3, 2026
NDT Pharmaceuticals Market Cap
NDT Pharmaceuticals has a market cap or net worth of $111.82 million as of June 3, 2026. Its market cap has increased by 140.98% in one year.
Market Cap
111.82M
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.62
Market Cap Chart
Since October 21, 2011, NDT Pharmaceuticals's market cap has increased from 2.76M to 111.82M, an increase of 3,952.51%. That is a compound annual growth rate of 28.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 2, 2026 | 111.82M | -57.56% |
| Dec 31, 2025 | 263.50M | 3,007.18% |
| Dec 31, 2024 | 8.48M | -13.47% |
| Dec 28, 2023 | 9.80M | 1,785.32% |
| Dec 31, 2021 | 519.82K | -69.72% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Northwest Biotherapeutics | 339.98M |
| Silence Therapeutics | 308.44M |
| Vaxart | 150.02M |
| Glorywin Entertainment Group | 149.60M |
| HST Global | 99.00M |
| Sangamo Therapeutics | 87.52M |
| BioStem Technologies | 70.94M |
| ProText Mobility | 54.51M |